Stimson Susan P 4
4 · Intersect ENT, Inc. · Filed Jun 17, 2019
Insider Transaction Report
Form 4
Stimson Susan P
Vice President, Marketing
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-06-13−350→ 6,550 totalExercise: $13.05Exp: 2027-01-17→ Common Stock (350 underlying) - Sale
Common Stock
2019-06-13$25.00/sh−350$8,750→ 35,982 total - Exercise/Conversion
Common Stock
2019-06-13$13.05/sh+350$4,568→ 36,332 total
Footnotes (3)
- [F1]Includes 21,969 restricted stock units.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2019.
- [F3]The vesting commencement date of the option was March 1st, 2017. 1/8th of the shares subject to the option vested on September 1st, 2017 and 1/48th of the shares subject to the option vests monthly thereafter over 42 months.